Moulay A. Alaoui-Jamali

Affiliations: 
McGill University, Montreal, QC, Canada 
Area:
Molecular Biology, Oncology, Microbiology Biology
Google:
"Moulay Alaoui-Jamali"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bakkar A, Alshalalfa M, Petersen LF, et al. (2016) microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients. Molecular Biology Reports
da Silva SD, Marchi FA, Xu B, et al. (2015) Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis. Oncotarget
Alaoui-Jamali MA, Morand GB, da Silva SD. (2015) ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics. Frontiers in Genetics. 6: 17
da Silva SD, Morand GB, Alobaid FA, et al. (2015) Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma. Clinical & Experimental Metastasis. 32: 55-63
Alaoui-Jamali MA, Cao YH, Bijian K, et al. (2015) Tumor-derived exosomes in metastasis signaling and implications Intercellular Communication in Cancer. 189-200
Morand GB, da Silva SD, Hier MP, et al. (2014) Insights into genetic and epigenetic determinants with impact on vitamin d signaling and cancer association studies: the case of thyroid cancer. Frontiers in Oncology. 4: 309
Xu B, Teng LH, Silva SD, et al. (2014) The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting. Cancer Medicine. 3: 14-24
Silva SD, Alaoui-Jamali MA, Hier M, et al. (2014) Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread. Clinical & Experimental Metastasis. 31: 307-16
da Silva SD, Alaoui-Jamali MA, Soares FA, et al. (2014) TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer. 120: 352-62
Bijian K, Lougheed C, Su J, et al. (2013) Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine British Journal of Cancer. 109: 2810-2818
See more...